
Dechra also bought stem cell developer Gallant, bringing gingivostomatitis and osteoarthritis programs for dogs and cats into its pipeline.
Changing terminology makes sense for the profession.
Regarding the recent commentary “
Tom Vollert-Morrison,
Practice manager,
Village Animal Clinic,
Voorheesville, New York






